Protein-targeting Therapy Found to Lessen Inflammation in Preclinical Study

Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses a protein-targeting therapy found to lessen inflammation in preclinical studies.

Multiple Sclerosis News Today’s columnist Jessie Ace reads a column by Jennifer Powell describes her experiences of traveling with Secondary Progressive Multiple sclerosis and the problems she’s faced because of her disability.

=====================================

Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

https://www.mayzent.com/?utm_source=changeinrms&utm_medium=vanityurl&utm_campaign=novartis_mayzent_2020&utm_content=soundcloud

=====================================

Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/

=====================================

To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/